These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7991422)

  • 21. Utility of Routine Exercise Testing to Detect Rate-Related QRS Widening in Patients Without Structural Heart Disease on Class Ic Antiarrhythmic Agents (Flecainide and Propafenone).
    Vallurupalli S; Pothineni NV; Deshmukh A; Paydak H
    Am J Cardiol; 2015 Sep; 116(5):730-2. PubMed ID: 26100588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous flecainide acetate for the clinical management of paroxysmal tachycardias.
    Nathan AW; Camm AJ; Bexton RS; Hellestrand KJ
    Clin Cardiol; 1987 May; 10(5):317-22. PubMed ID: 3109795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proarrhythmic effects of class Ic drugs.
    Moroe K; Annoura M; Matsuo K; Yamanouchi Y; Kumagai K; Arakawa K
    Clin Ther; 1993; 15(3):559-66. PubMed ID: 8364947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Tachycardia with wide QRS. Limitations of electrocardiographic criteria in patients treated with anti-arrhythmia agents].
    Le Davay M; Victor J; Dupuis JM; Merheb M; Tran P; Tadeï A
    Ann Cardiol Angeiol (Paris); 1994 May; 43(5):253-5. PubMed ID: 8074416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tachycardia due to atrial flutter with rapid 1:1 conduction following treatment of atrial fibrillation with flecainide.
    Taylor R; Gandhi MM; Lloyd G
    BMJ; 2010 Mar; 340():b4684. PubMed ID: 20219811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reentrant arrhythmias in the subacute infarction period. The proarrhythmic effect of flecainide acetate on functional reentrant circuits.
    Restivo M; Yin H; Caref EB; Patel AI; Ndrepepa G; Avitable MJ; Assadi MA; Isber N; el-Sherif N
    Circulation; 1995 Feb; 91(4):1236-46. PubMed ID: 7850964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using the right drug: a treatment algorithm for regular supraventricular tachycardias.
    Lévy S; Ricard P
    Eur Heart J; 1997 May; 18 Suppl C():C27-32. PubMed ID: 9152672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What caused this wide-complex tachycardia?
    Tsiperfal A; Thompson C
    Prog Cardiovasc Nurs; 2003; 18(4):201-2. PubMed ID: 14605524
    [No Abstract]   [Full Text] [Related]  

  • 29. A case of acute ventricular capture threshold rise associated with flecainide acetate.
    Kang TS; Yoon YW; Park S; Hong BK; Kim D; Kwon HM; Kim HS
    Yonsei Med J; 2006 Feb; 47(1):152-4. PubMed ID: 16502500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regular ventricular rhythms before conversion of recent onset atrial fibrillation to sinus rhythm.
    Botto GL; Bonini W; Broffoni T; Cappelletti G; Falcone C; Lombardi R; Paulesu A; Pedraglio E; Ferrari G
    Pacing Clin Electrophysiol; 1994 Nov; 17(11 Pt 2):2114-7. PubMed ID: 7845827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia.
    Hellestrand KJ
    Am J Cardiol; 1996 Jan; 77(3):83A-88A. PubMed ID: 8607396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
    Hopson JR; Buxton AE; Rinkenberger RL; Nademanee K; Heilman JM; Kienzle MG
    Am J Cardiol; 1996 Jan; 77(3):72A-82A. PubMed ID: 8607395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amplification of flecainide-induced ventricular conduction slowing by exercise. A potentially significant clinical consequence of use-dependent sodium channel blockade.
    Ranger S; Talajic M; Lemery R; Roy D; Nattel S
    Circulation; 1989 May; 79(5):1000-6. PubMed ID: 2540920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardias.
    Hellestrand KJ; Nathan AW; Bexton RS; Spurrell RA; Camm AJ
    Am J Cardiol; 1983 Mar; 51(5):770-6. PubMed ID: 6829436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ECGs in the ED.
    Tanel RE
    Pediatr Emerg Care; 2008 Nov; 24(11):803-4. PubMed ID: 19018229
    [No Abstract]   [Full Text] [Related]  

  • 36. The proarrhythmic effects of flecainide.
    Nathan AW; Hellestrand KJ; Bexton RS; Spurrell RA; Camm AJ
    Drugs; 1985; 29 Suppl 4():45-53. PubMed ID: 4006779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sudden death of a horse with supraventricular tachycardia following oral administration of flecainide acetate.
    Dembek KA; Hurcombe SD; Schober KE; Toribio RE
    J Vet Emerg Crit Care (San Antonio); 2014; 24(6):759-63. PubMed ID: 25388866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wide Complex Tachycardia in a Patient With a History of Atrial Fibrillation.
    Hegde S; Kumar V
    JAMA Intern Med; 2016 Mar; 176(3):386-8. PubMed ID: 26784121
    [No Abstract]   [Full Text] [Related]  

  • 39. Exercise-induced ventricular tachycardia as a manifestation of flecainide toxicity.
    Hoffmann A; Wenk M; Follath F
    Int J Cardiol; 1986 Jun; 11(3):353-5. PubMed ID: 3721634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The differential diagnosis of a regular tachycardia with a wide QRS complex on the 12-lead ECG: ventricular tachycardia, supraventricular tachycardia with aberrant intraventricular conduction, and supraventricular tachycardia with anterograde conduction over an accessory pathway.
    Antunes E; Brugada J; Steurer G; Andries E; Brugada P
    Pacing Clin Electrophysiol; 1994 Sep; 17(9):1515-24. PubMed ID: 7991423
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.